Concepts in B-cell Acute Lymphoblastic Leukemia Pathogenesis.
B-cell acute lymphoblastic leukemia
disparities
leukemic transformation
patient survival
tumor metabolism
Journal
Journal of leukocyte biology
ISSN: 1938-3673
Titre abrégé: J Leukoc Biol
Pays: England
ID NLM: 8405628
Informations de publication
Date de publication:
18 Jan 2024
18 Jan 2024
Historique:
received:
26
10
2023
revised:
22
12
2023
accepted:
08
01
2024
medline:
20
1
2024
pubmed:
20
1
2024
entrez:
20
1
2024
Statut:
aheadofprint
Résumé
B-cell acute lymphoblastic leukemia (B-ALL) arises from genetic alterations impacting B-cell progenitors, ultimately leading to clinically overt disease. Extensive collaborative efforts in basic and clinical research have significantly improved patient prognoses. Nevertheless, a subset of patients demonstrate resistance to conventional chemotherapeutic approaches and emerging immunotherapeutic interventions. This review highlights the mechanistic underpinnings governing B-ALL transformation. Beginning with exploring normative B-cell lymphopoiesis, we delineate the influence of recurrent germline and somatic genetic aberrations on the perturbation of B-cell progenitor differentiation and pro-tumorigenic signaling, thereby facilitating the neoplastic transformation underlying B-ALL progression. Additionally, we highlight recent advances in the multifaceted landscape of B-ALL, encompassing metabolic reprogramming, microbiome influences, inflammation, and the discernible impact of socioeconomic and racial disparities on B-ALL transformation and patient survival.
Identifiants
pubmed: 38243586
pii: 7577740
doi: 10.1093/jleuko/qiae015
pii:
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© The Author(s) 2024. Published by Oxford University Press on behalf of Society for Leukocyte Biology. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.